February 6th 2026
Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist.
February 4th 2026
Collaborative care use has surged 26-fold, but state reimbursement gaps leave many patients without integrated mental health care in primary care.
January 17th 2026
The ACCESS Model signals a shift toward outcome-aligned payments and a necessary reframing of what “value” actually means.
December 31st 2025
AI revolutionizes pharmacy by automating workloads, enhancing patient care, and navigating drug pricing challenges amid evolving federal policies.
December 28th 2025
The most-viewed content focused on the “One Big Beautiful Bill,” the Most Favored Nation drug policy, and other changes under the Trump administration.